ED Coding & Reimbursement Alert - 2004 Issue 39
Fee To Be You And Me
Subscribe or sign in to view the full article.
Article Overview
This short policy article explains how Medicare responded to concerns about reduced payment rates for inhalation drug supplies by considering a monthly dispensing fee. It summarizes the Government Accountability Office’s role, the Centers for Medicare & Medicaid Services’ planned fee range for 2005, and the broader provider access concerns raised by respiratory care organizations. It is relevant to billing professionals, respiratory therapy suppliers, and healthcare administrators following Medicare reimbursement policy.
Why This Topic Matters
Changes to inhalation drug payment policy can affect supplier participation, patient access, and operational planning for respiratory care providers. Readers tracking Medicare reimbursement and supplier cost coverage will want to understand the policy context described here.
What You Will Learn
- How a Medicare payment issue for inhalation drugs was addressed at the policy level
- What organizations were involved in reviewing and responding to the payment concerns
- Why supplier dispensing costs were part of the discussion
- How the article frames the potential impact on access to inhalation therapy supplies
Who Should Read This
- Medical coders
- Billing specialists
- Respiratory therapy suppliers
- Healthcare administrators
- Compliance staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com